4 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Rate of Progression in USH2A-related Retinal DegenerationUsher syndrome type 2A, retinitis pigmentosa 39Active, not recruitingNot stated2026-07-23NCT03146078
A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis PigmentosaEye Diseases, Hereditary, eye disorder, retinal degeneration, retinal disorderActive, not recruitingPhase 22026-06-25NCT07174726
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of AgeNeurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, amblyopia, brain disorder, central nervous system disorder, eye disorder, nervous system disorder, vision disorderRecruitingPhase 32026-02-11NCT06524882
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2neurotrophic keratopathyRecruitingPhase 32025-12-23NCT05555589